Clinical trialNCT04649255CompletedInterventional

Treatment of Peripheral Arterial Hemorrhage With Lava LES (The LAVA Study)

SponsorBlackSwan Vascular, Inc.Enrollment113Peripheral Arterial Hemorrhage

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

To evaluate the safety and effectiveness of the Lava LES for the embolic treatment of arterial hemorrhage in the peripheral vasculature.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Bulent Arslan, MD
Rush University Medical Center
Principal Investigator
clinicaltrials.gov ↗
Mahmood Razavi, MD
St. Joseph Heart and Vascular Center
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of California
Irvine, California, United States
University of Southern California
Los Angeles, California, United States
University of Miami
Miami, Florida, United States
Rush University Medical Center
Chicago, Illinois, United States
Indiana University
Indianapolis, Indiana, United States
University of Maryland
Baltimore, Maryland, United States
Albany University Medical Center
Albany, New York, United States
Icahn School of Medicine at Mount Sinai
New York, New York, United States
University of North Carolina
Chapel Hill, North Carolina, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 14 Apr 2021
Primary completion: 17 Aug 2022
Completion: 17 Aug 2022
Last update posted: 12 Apr 2024
Registered enrollment: 113
Registry id: NCT04649255

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.